SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-18-050753
Filing Date
2018-08-09
Accepted
2018-08-09 07:32:01
Documents
74
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q a18-14041_110q.htm 10-Q 1737400
2 EX-31.1 a18-14041_1ex31d1.htm EX-31.1 11787
3 EX-31.2 a18-14041_1ex31d2.htm EX-31.2 11132
4 EX-32.1 a18-14041_1ex32d1.htm EX-32.1 9021
  Complete submission text file 0001104659-18-050753.txt   7831085

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT neos-20180630.xml EX-101.INS 1658107
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT neos-20180630.xsd EX-101.SCH 61795
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT neos-20180630_cal.xml EX-101.CAL 50753
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT neos-20180630_def.xml EX-101.DEF 287267
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT neos-20180630_lab.xml EX-101.LAB 603254
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT neos-20180630_pre.xml EX-101.PRE 477669
Mailing Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050
Business Address 2940 N. HIGHWAY 360 SUITE 400 GRAND PRAIRIE TX 75050 972.408.1360
Neos Therapeutics, Inc. (Filer) CIK: 0001467652 (see all company filings)

IRS No.: 270395455 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37508 | Film No.: 181003188
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences